doi:10.3969/j.issn.1004-583X.2024.06.012

Abstract

CLC Number:

R582.1

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2024.06.012

https://huicui.hebmu.edu.cn/EN/Y2024/V39/I6/554

References 37

[1]	Carsote M, Nistor C. Forestalling hungry bone syndrome after parathyroidectomy in patients with primary and renal hyperparathyroidism[J]. Diagnostics (Basel), 2023, 13(11):1953.
[2]	Wang M, Chen B, Zou X, et al. A nomogram to predict hungry bone syndrome after parathyroidectomy in patients with secondary hyperparathyroidism[J]. J Surg Res, 2020, 255: 33-41. doi: S0022-4804(20)30309-7 pmid: 32540578
[3]	Stanbury SW, Lumb GA, Nicholson WF. Elective subtotal parathyroidectomy for renal hyperparathyroidism[J]. Lancet, 1960, 1(7128): 793-799. pmid: 13833730
[4]	Jain N, Reilly RF. Hungry bone syndrome[J]. Curr Opin Nephrol Hypertens, 2017, 26(4): 250-255.
[5]	Zhang Y, Lu Y, Feng S, et al. Evaluation of laboratory parameters and symptoms after parathyroidectomy in dialysis patients with secondary hyperparathyroidism[J]. Ren Fail, 2019, 41(1): 921-929. doi: 10.1080/0886022X.2019.1666724 pmid: 31573378
[6]	Lau WL, Obi Y, Kalantar-Zadeh K. Parathyroidectomy in the management of secondary hyperparathyroidism[J]. Clin J Am Soc Nephrol, 2018, 13(6): 952-961.
[7]	贺青卿, 田文. 慢性肾脏病继发甲状旁腺功能亢进外科临床实践中国专家共识(2021版)[J]. 中国实用外科杂志, 2021, 41(8): 841-848.
[8]	Wang L, Zhang X, Hu F, et al. Impact of enhanced recovery after surgery program for hungry bone syndrome in patients on maintenance hemodialysis undergoing parathyroidectomy for secondary hyperparathyroidism[J]. Ann Surg Treat Res, 2022, 103(5): 264-270. doi: 10.4174/astr.2022.103.5.264 pmid: 36452310
[9]	Cao L, Sun X, Zhang T, et al. A reappraisal of risk factors for early hypocalcemia after parathyroidectomy in dialysis patients[J]. Updates Surg, 2022, 74(6): 1961-1970. doi: 10.1007/s13304-022-01395-2 pmid: 36194380
[10]	Gao D, Lou Y, Cui Y, et al. Risk factors for hypocalcemia in dialysis patients with refractory secondary hyperparathyroidism after parathyroidectomy: A meta-analysis[J]. Ren Fail, 2022, 44(1): 503-512. doi: 10.1080/0886022X.2022.2048856 pmid: 35285377
[11]	Zhao S, Gan W, Xie W, et al. A single-center experience of parathyroidectomy in 1500 cases for secondary hyperparathyroidism: A retrospective study[J]. Ren Fail, 2022, 44(1): 23-29. doi: 10.1080/0886022X.2021.2016445 pmid: 35094636
[12]	Taterra D, Wong L, Vikse J, et al. The prevalence and anatomy of parathyroid glands: A meta-analysis with implications for parathyroid surgery[J]. Langenbecks Arch Surg, 2019, 404(1): 63-70.
[13]	郭兴, 陈湘秋, 黄树平. 甲状旁腺的局部解剖及临床应用[J]. 解剖学研究, 2002, (4): 296-297.
[14]	Weber T, Dotzenrath C, Dralle H, et al. Management of primary and renal hyperparathyroidism: Guidelines from the German Association of Endocrine Surgeons (CAEK)[J]. Langenbecks Arch Surg, 2021, 406(3): 571-585.
[15]	Liu M, Qiu N, Zha S, et al. To assess the effects of parathyroidectomy (TPTX versus TPTX+AT) for secondary hyperparathyroidism in chronic renal failure: A systematic review and meta-analysis[J]. Int J Surg, 2017, 44: 353-362.
[16]	Chen J, Jia X, KONG X, et al. Total parathyroidectomy with autotransplantation versus subtotal parathyroidectomy for renal hyperparathyroidism: A systematic review and meta-analysis[J]. Nephrology, 2017, 22(5): 388-396. doi: 10.1111/nep.12801 pmid: 27085089
[17]	艾向南, 金昌国, 欧阳才国, 等. 继发性甲状旁腺功能亢进患者甲状旁腺切除术后重度低钙血症相关因素分析[J]. 滨州医学院学报, 2015, 38(4): 257-259.
[18]	Zou Y, Zhang N, Tang Y, et al. Predictive markers for severe hypocalcemia in dialysis patients with secondary hyperparathyroidism after near-total parathyroidectomy[J]. Ann Palliat Med, 2021, 10(10): 10712-10719. doi: 10.21037/apm-21-2509 pmid: 34763432
[19]	Anwar F, Abraham J, Nakshabandi A, et al. Treatment of hypocalcemia in hungry bone syndrome: A case report[J]. Int J Surg Case Rep, 2018, 51: 335-339.
[20]	Ge Y, Yang G, Wang N, et al. Bone metabolism markers and hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism[J]. Int Urol Nephrol, 2019, 51(8): 1443-1449. doi: 10.1007/s11255-019-02217-y pmid: 31264087
[21]	He C, Zhang Y, Li L, et al. Risk factor analysis and prediction of severe hypocalcemia after total parathyroidectomy without auto-transplantation in patients with secondary hyperparathyroidism[J]. Int J Endocrinol, 2023, 2023: 1901697.
[22]	Yan L, Xiong Q, Xu Q, et al. Study on the correlation between mineral bone metabolism and CRP in patients with SHPT during perioperative period[J]. Immun Inflamm Dis, 2023, 11(4): e828.
[23]	Komaba H, Hamano T, Fujii N, et al. Parathyroidectomy vs cinacalcet among patients undergoing hemodialysis[J]. J Clin Endocrinol Metab, 2022, 107(7): 2016-2025.
[24]	Hamouda M, Dhia NB, Aloui S, et al. Predictors of early post-operative hypocalcemia after parathyroidectomy for secondary hyperparathyroidism[J]. Saudi J Kidney Dis Transpl, 2013, 24(6): 1165-1169. doi: 10.4103/1319-2442.121273 pmid: 24231478
[25]	Mace ML, Egstrand S, Morevati M, et al. New insights to the crosstalk between vascular and bone tissue in chronic kidney disease-mineral and bone disorder[J]. Metabolites, 2021, 11(12): 849.
[26]	Yamada S, Tsuruya K, Kitazono T, et al. Emerging cross-talks between chronic kidney disease-mineral and bone disorder (CKD-MBD) and malnutrition-inflammation complex syndrome (MICS) in patients receiving dialysis[J]. Clin Exp Nephrol, 2022, 26(7): 613-629.
[27]	Philips R, Nulty P, Seim N, et al. Predicting transient hypocalcemia in patients with unplanned parathyroidectomy after thyroidectomy[J]. Am J Otolaryngol, 2019, 40(4): 504-508.
[28]	Wetmore JB, Liu J, Do TP, et al. Changes in secondary hyperparathyroidism-related biochemical parameters and medication use following parathyroidectomy[J]. Nephrol Dial Transplan, 2016, 31(1): 103-111.
[29]	Benabdelkamel H, Masood A, Ekhzaimy AA, et al. Proteomics profiling of the urine of patients with hyperthyroidism after anti-thyroid treatment[J]. Molecules, 2021, 26(7):1991.
[30]	Donahue C, Pantel HJ, Yarlagadda BB, et al. Does preoperative calcium and calcitriol decrease rates of post-thyroidectomy hypocalcemia? A randomized clinical trial[J]. J Am Coll Surg, 2021, 232(6): 848-854.
[31]	Duque EJ, Elias RM, Moysés RMA. Parathyroid hormone: A uremic toxin[J]. Toxins, 2020, 12(3):189.
[32]	Disthabanchong S, Saeseow S, Khunapornphairote S, et al. Improvement of nutritional status after parathyroidectomy in patients receiving maintenance hemodialysis[J]. Front Med (Lausanne), 2023, 10: 1132566.
[33]	成铭, 黄碧红, 陶冶, 等. 维持性血液透析继发性甲状旁腺功能亢进患者甲状旁腺切除术后低钙血症的危险因素分析[J]. 中华肾脏病杂志, 2022, 38(5): 397-405. doi: 10.3760/cma.j.cn441217-20210803-00057
[34]	Ho LY, Wong PN, Sin HK, et al. Risk factors and clinical course of hungry bone syndrome after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism[J]. BMC Nephrol, 2017, 18(1): 12.
[35]	Erbil Y, Bozbora A, Ozbey N, et al. Predictive value of age and serum parathormone and vitamin d3 levels for postoperative hypocalcemia after total thyroidectomy for nontoxic multinodular goiter[J]. Arch Surg, 2007, 142(12): 1182-1187. doi: 10.1001/archsurg.142.12.1182 pmid: 18086985
[36]	Yang M, Zhang L, Huang L, et al. Factors predictive of critical value of hypocalcemia after total parathyroidectomy without autotransplantation in patients with secondary hyperparathyroidism[J]. Ren Fail, 2016, 38(8): 1224-1227. doi: 10.1080/0886022X.2016.1202731 pmid: 27359159
[37]	林佳伟, 肖映胜, 杨熙鸿, 等. 继发性甲状旁腺功能亢进症术后低钙血症相关因素分析[J]. 新医学, 2021, 52(5): 343-346. doi: 10.3969/j.issn.0253-9802.2021.05.009

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 37

Related Articles 12

Recommended Articles

Metrics

Comments

[1]	. [J]. Clinical Focus, 2022, 37(7): 648-652.
[2]	Yang Jing, Tian Yongfeng, Qu Hua. Ultrasound-guided percutaneous microwave ablation for primary hyperparathyroidism: a case report and literature review [J]. Clinical Focus, 2021, 36(6): 548-551.
[3]	. [J]. CLINICAL FOCUS, 2013, 28(11): 1280-1281.
[4]	. [J]. Clinical Focus, 2012, 27(5): 436-0.
[5]	. [J]. Clinical Focus, 2011, 26(22): 2015-0.
[6]	. [J]. CLINICAL FOCUS, 2009, 24(5): 389-0.
[7]	. [J]. CLINICAL FOCUS, 2008, 23(24): 1800-1801.
[8]	. [J]. CLINICAL FOCUS, 2008, 23(9): 646-647.
[9]	. [J]. CLINICAL FOCUS, 2007, 22(23): 1730-1731.
[10]	. [J]. CLINICAL FOCUS, 2007, 22(15): 1124-1125.
[11]	. [J]. CLINICAL FOCUS, 2005, 20(10): 562-563.
[12]	. [J]. CLINICAL FOCUS, 2003, 18(16): 952-953.